These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 27625691)

  • 1. Transapical transcatheter aortic valve implantation followed by transfemoral transcatheter edge-to-edge repair of the tricuspid valve using the MitraClip system - a new treatment concept for an inoperable patient with significant aortic stenosis and severe tricuspid valve regurgitation.
    Kowalski M; Franz N; Hofmann S; Ritter F; Thale J; Warnecke H
    Postepy Kardiol Interwencyjnej; 2016; 12(3):262-6. PubMed ID: 27625691
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous transfemoral transcatheter mitral and tricuspid valve edge-to-edge repair (using MitraClip system) completed by atrial septal defect occlusion in a surgically inoperable patient. First-in-human report.
    Kowalski M; Franz N; Ritter F; Hofmann S; Stabel-Mahassine C; Warnecke H; Thale J
    Kardiochir Torakochirurgia Pol; 2015 Dec; 12(4):295-7. PubMed ID: 26855642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-Stage Transcatheter Aortic Valve Implantation and Transcatheter Edge-to-Edge Tricuspid Valve Repair for Double Valve Dysfunction in a High-Risk Patient.
    Cuko B; Baudo M; Ternacle J; Leroux L; Modine T
    Cureus; 2023 Sep; 15(9):e45648. PubMed ID: 37868418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Treatment of Mitral Regurgitation after Transapical Transcatheter Aortic Valve Implantation by Percutaneous Edge-to-edge Mitral Valve Repair (MitraClip
    Okada A; Kanzaki H; Amaki M; Kataoka Y; Miyamoto K; Hamatani Y; Fujino M; Takahama H; Hasegawa T; Shimahara Y; Morita Y; Sugano Y; Kusano K; Ohnishi Y; Fujita T; Kobayashi J; Anzai T; Yasuda S
    Intern Med; 2018 Apr; 57(8):1105-1109. PubMed ID: 29269670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
    Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimally invasive versus transapical versus transfemoral aortic valve implantation: A one-to-one-to-one propensity score-matched analysis.
    Furukawa N; Kuss O; Emmel E; Scholtz S; Scholtz W; Fujita B; Ensminger S; Gummert JF; Börgermann J
    J Thorac Cardiovasc Surg; 2018 Nov; 156(5):1825-1834. PubMed ID: 29861110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bivalvular transcatheter treatment of high-surgical-risk patients with coexisting severe aortic stenosis and significant mitral regurgitation.
    Rudolph V; Schirmer J; Franzen O; Schlüter M; Seiffert M; Treede H; Reichenspurner H; Blankenberg S; Baldus S
    Int J Cardiol; 2013 Aug; 167(3):716-20. PubMed ID: 22459381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tricuspid regurgitation and the right heart on survival after transcatheter aortic valve replacement: insights from the Placement of Aortic Transcatheter Valves II inoperable cohort.
    Lindman BR; Maniar HS; Jaber WA; Lerakis S; Mack MJ; Suri RM; Thourani VH; Babaliaros V; Kereiakes DJ; Whisenant B; Miller DC; Tuzcu EM; Svensson LG; Xu K; Doshi D; Leon MB; Zajarias A
    Circ Cardiovasc Interv; 2015 Apr; 8(4):. PubMed ID: 25855679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse Cardiac Remodeling After Transcatheter Treatment of Severe Tricuspid Regurgitation Using the Edge-to-Edge MitraClip Technique.
    Ledwoch J; Fellner C; Poch F; Schlatterbeck L; Dommasch M; Dirschinger R; Stundl A; Laugwitz KL; Kupatt C; Hoppmann P
    J Invasive Cardiol; 2019 Apr; 31(4):89-93. PubMed ID: 30927530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First transfemoral percutaneous edge-to-edge repair of the tricuspid valve using the MitraClip system.
    Wengenmayer T; Zehender M; Bothe W; Bode C; Grundmann S
    EuroIntervention; 2016 Apr; 11(13):1541-4. PubMed ID: 27107316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond the learning curve: transapical versus transfemoral transcatheter aortic valve replacement in the treatment of severe aortic valve stenosis.
    Greason KL; Suri RM; Nkomo VT; Rihal CS; Holmes DR; Mathew V
    J Card Surg; 2014 May; 29(3):303-7. PubMed ID: 24601949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective.
    Doble B; Blackhouse G; Goeree R; Xie F
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):52-60.e3. PubMed ID: 22795437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous interventions for mitral and tricuspid heart valve diseases.
    Tabata N; Sugiura A; Tsujita K; Nickenig G; Sinning JM
    Cardiovasc Interv Ther; 2020 Jan; 35(1):62-71. PubMed ID: 31396890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant Transapical Transcatheter Valve Implantations: Edwards Sapien Valve for Severe Mitral Regurgitation in a Patient with Failing Mitral Bioprostheses and JenaValve for the Treatment of Pure Aortic Regurgitation.
    Aydin U; Gul M; Aslan S; Akkaya E; Yildirim A
    Heart Surg Forum; 2015 Apr; 18(2):E053-5. PubMed ID: 25924031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after transapical and transfemoral aortic valve implantation: talking about two different patient populations.
    Bleiziffer S; Ruge H; Mazzitelli D; Hutter A; Opitz A; Bauernschmitt R; Lange R
    J Thorac Cardiovasc Surg; 2009 Nov; 138(5):1073-80. PubMed ID: 19765739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis.
    Herrmann HC; Thourani VH; Kodali SK; Makkar RR; Szeto WY; Anwaruddin S; Desai N; Lim S; Malaisrie SC; Kereiakes DJ; Ramee S; Greason KL; Kapadia S; Babaliaros V; Hahn RT; Pibarot P; Weissman NJ; Leipsic J; Whisenant BK; Webb JG; Mack MJ; Leon MB;
    Circulation; 2016 Jul; 134(2):130-40. PubMed ID: 27400898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Procedural and Clinical Outcomes in Patients With Symptomatic Tricuspid Regurgitation Undergoing Transcatheter Edge-to-Edge Repair.
    Besler C; Orban M; Rommel KP; Braun D; Patel M; Hagl C; Borger M; Nabauer M; Massberg S; Thiele H; Hausleiter J; Lurz P
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1119-1128. PubMed ID: 29929631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter valve interventions in heart failure: new answers to old questions.
    Tadic M; Cuspidi C
    Heart Fail Rev; 2018 Nov; 23(6):859-870. PubMed ID: 29654449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of transapical versus transfemoral TAVI in a real world population of 1000 patients with severe symptomatic aortic stenosis.
    Schymik G; Würth A; Bramlage P; Herbinger T; Heimeshoff M; Pilz L; Schymik JS; Wondraschek R; Süselbeck T; Gerhardus J; Luik A; Gonska BD; Posival H; Schmitt C; Schröfel H
    Circ Cardiovasc Interv; 2015 Jan; 8(1):. PubMed ID: 25552563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcomes After Transapical and Transfemoral Transcatheter Aortic Valve Insertion: An Evolving Experience.
    Murashita T; Greason KL; Pochettino A; Sandhu GS; Nkomo VT; Bresnahan JF; Reeder GS; Holmes DR; Rihal CS; Mathew V
    Ann Thorac Surg; 2016 Jul; 102(1):56-61. PubMed ID: 27112646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.